Company Name: Minerva Neurosciences, Inc.    

Minerva Neurosciences, Inc. is a clinical stage biopharmaceutical company.  The company is engaged in the development of treatments for central nervous system disorders.  The company’s developmental pipeline includes product candidates for conditions that include:

  • Schizophrenia
  • Insomnia
  • Major depressive disorder
  • Parkinson’s disease

Ticker Symbol: NERV (NASDAQ)

Company Website:

Headquarters: Waltham, MA